Table 2.
Mutations | EOPC (n=53) | LOPC | P |
---|---|---|---|
KRAS n=(%) | 48 (90.5%) | 81 (91%) | 0.832 |
TP 53 n=(%) | 37 (69.8%) | 63 (70.8%) | 0.946 |
CDKN2A n=(%) | 11 (20.7%) | 14 (15.7%) | 0.594 |
SMAD4 n=(%) | 5 (9.4%) | 22 (24.7%) | 0.043 |
Mutations | EOPC (n=53) | LOPC | P |
---|---|---|---|
KRAS n=(%) | 48 (90.5%) | 81 (91%) | 0.832 |
TP 53 n=(%) | 37 (69.8%) | 63 (70.8%) | 0.946 |
CDKN2A n=(%) | 11 (20.7%) | 14 (15.7%) | 0.594 |
SMAD4 n=(%) | 5 (9.4%) | 22 (24.7%) | 0.043 |